Lucid Diligence Brief - BioPharma

GSK Acquires Nuvalent to Expand Oncology Pipeline | Lucid Diligence Brief

GSK strengthens its oncology portfolio with Nuvalent acquisition, adding…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: PAQ Therapeutics Series B for PT0511 pan-KRAS degrader

Lucid Diligence Brief: PAQ Therapeutics Series B for PT0511 pan-KRAS degrader…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Neurable raises $35M Series A to scale brain-signal AI

Lucid Diligence Brief: Neurable raises $35M Series A to scale brain-signal AI…


Privacy Preference Center